Upregulation of RIPK1 implicates in HEK 293T cell death upon transient transfection of A53T-α-synuclein.

[1]  A. Fakhri,et al.  High efficiency of Ag0 decorated Cu2MoO4 nanoparticles for heterogeneous photocatalytic activation, bactericidal system, and detection of glucose from blood sample. , 2022, Journal of photochemistry and photobiology. B, Biology.

[2]  A. Fakhri,et al.  Bio-photoelectrochemical degradation, and photocatalysis process by the fabrication of copper oxide/zinc cadmium sulfide heterojunction nanocomposites: Mechanism, microbial community and antifungal analysis. , 2022, Chemosphere.

[3]  S. Hosseinkhani,et al.  Development of a bioluminescence assay for BIR2- Caspase3 interaction through split luciferase complementary assay , 2022, Biochemical Engineering Journal.

[4]  A. Fakhri,et al.  Fabrication of novel rational Ti-Sn doped Cu-ferrite nanoparticles for robust photocatalysis reaction, magnetic resonance imaging, and chemo-magneto-photo-thermal therapy , 2022, Surfaces and Interfaces.

[5]  A. Fakhri,et al.  Synergistic activities of silver indium sulfide/nickel molybdenum sulfide nanostructures anchored on clay mineral for light-driven bactericidal performance, and detection of uric acid from gout patient serum. , 2022, Journal of photochemistry and photobiology. B, Biology.

[6]  Yehya M. Ahmed,et al.  Preparation, photocatalytic and antibacterial studies on novel doped ferrite nanoparticles: Characterization and Mechanism evaluation , 2022, Colloids and Surfaces A: Physicochemical and Engineering Aspects.

[7]  D. Rubinsztein,et al.  A New Zebrafish Model to Measure Neuronal α-Synuclein Clearance In Vivo , 2022, Genes.

[8]  Y. Zhang,et al.  MCC950 ameliorates the dementia symptom at the early age of line M83 mouse and reduces hippocampal α-synuclein accumulation. , 2022, Biochemical and biophysical research communications.

[9]  S. Ramakrishna,et al.  Ag doped Sn3O4 nanostructure and immobilized on hyperbranched polypyrrole for visible light sensitized photocatalytic, antibacterial agent and microbial detection process. , 2022, Journal of photochemistry and photobiology. B, Biology.

[10]  S. Ha,et al.  Differences of Key Proteins between Apoptosis and Necroptosis , 2021, BioMed research international.

[11]  Zhengxin Fei,et al.  A strategy of Silver Ferrite/Bismuth ferrite nano-hybrids synthesis for synergetic white-light photocatalysis, antibacterial systems and peroxidase-like activity , 2021, Journal of Photochemistry and Photobiology A: Chemistry.

[12]  Mohsen Isazadeh,et al.  Split-luciferase complementary assay of NLRP3 PYD-PYD interaction indicates inflammasome formation during inflammation. , 2021, Analytical biochemistry.

[13]  S. Xiao,et al.  Synthesis of spinel Tin ferrite decorated on Bismuth ferrite nanostructures for synergetic photocatalytic, superior drug delivery, and antibacterial efficiencies , 2021, Surfaces and Interfaces.

[14]  Junying Yuan,et al.  Genetic Regulation of RIPK1 and Necroptosis. , 2021, Annual review of genetics.

[15]  D. Bokov,et al.  Quick and sensitive colorimetric detection of amino acid with functionalized-silver/copper nanoparticles in the presence of cross linker, and bacteria detection by using DNA-template nanoparticles as peroxidase activity , 2021, Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.

[16]  A. Fakhri,et al.  Fabrication of Cu2MoS4 decorated WO3 nano heterojunction embedded on chitosan: Robust photocatalytic efficiency, antibacterial performance, and bacteria detection by peroxidase activity. , 2021, Journal of photochemistry and photobiology. B, Biology.

[17]  Xiaobing Wang,et al.  Novel insights into RIPK1 as a promising target for future Alzheimer's disease treatment. , 2021, Pharmacology & therapeutics.

[18]  H. Fearnhead,et al.  Apoptosome Formation through Disruption of the K192-D616 Salt Bridge in the Apaf-1 Closed Form , 2021, ACS omega.

[19]  A. Rothman,et al.  Viral Suppression of RIPK1-Mediated Signaling , 2021, mBio.

[20]  K. Adibkia,et al.  Silver nanoparticles induce the cardiomyogenic differentiation of bone marrow derived mesenchymal stem cells via telomere length extension , 2021, Beilstein journal of nanotechnology.

[21]  Behnaz Valipour,et al.  Alginate/gelatin encapsulation promotes NK cells differentiation potential of bone marrow resident C-kit+ hematopoietic stem cells. , 2021, International journal of biological macromolecules.

[22]  J. Amaral,et al.  Oxidative stress and regulated cell death in Parkinson’s disease , 2021, Ageing Research Reviews.

[23]  Tsui-Wen Chou,et al.  Fibrillar α-synuclein induces neurotoxic astrocyte activation via RIP kinase signaling and NF-κB , 2020, Cell Death & Disease.

[24]  S. Hosseinkhani,et al.  Transient transfection of WT-αS and A53T-αS brought about a mild apoptosis due to degradation of released cytochrome c through PARC. , 2020, International journal of biological macromolecules.

[25]  M. Tansey,et al.  Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s disease , 2020, Scientific Reports.

[26]  S. Hosseinkhani,et al.  Effects of doxorubicin and docetaxel on susceptibility to apoptosis in high expression level of survivin in HEK and HEK-S cell lines as in vitro models. , 2020, Biochemical and biophysical research communications.

[27]  J. Pu,et al.  NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin , 2020, Neuroscience.

[28]  Maryam Nikkhah,et al.  Optimization of Experimental Variables Influencing Apoptosome Biosensor in HEK293T Cells , 2020, Sensors.

[29]  S. Fossati,et al.  Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease. , 2019, Journal of Alzheimer's disease : JAD.

[30]  C. Culmsee,et al.  Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons , 2019, Cell Death & Disease.

[31]  M. P. Dobay,et al.  Efficient apoptosis requires feedback amplification of upstream apoptotic signals by effector caspase-3 or -7 , 2019, Science Advances.

[32]  S. Dohgu,et al.  Monomeric α-synuclein induces blood-brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro. , 2019, Microvascular research.

[33]  A. Degterev,et al.  Targeting RIPK1 for the treatment of human diseases , 2019, Proceedings of the National Academy of Sciences.

[34]  P. Poindron,et al.  Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins , 2019, PloS one.

[35]  K. Bae,et al.  The roles of ubiquitination in extrinsic cell death pathways and its implications for therapeutics. , 2019, Biochemical pharmacology.

[36]  D. Hyun.  Plasma membrane redox enzymes: new therapeutic targets for neurodegenerative diseases , 2019, Archives of pharmacal research.

[37]  Y. Kapila,et al.  The role of caspase‐8, caspase‐9, and apoptosis inducing factor in periodontal disease , 2018, Journal of periodontology.

[38]  Junying Yuan,et al.  Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases , 2018, Nature Reviews Neuroscience.

[39]  P. Sorensen,et al.  Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity , 2018, Acta Neuropathologica Communications.

[40]  Junying Yuan,et al.  Regulation of a distinct activated RIPK1 intermediate bridging complex I and complex II in TNFα-mediated apoptosis , 2018, Proceedings of the National Academy of Sciences.

[41]  P. Uchil,et al.  Analysis of Cell Viability by the MTT Assay. , 2018, Cold Spring Harbor protocols.

[42]  C. Culmsee,et al.  Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson’s Disease Etiopathology , 2018, Molecular Neurobiology.

[43]  S. Hosseinkhani,et al.  Insufficient Apaf-1 expression in early stages of neural differentiation of human embryonic stem cells might protect them from apoptosis. , 2018, European journal of cell biology.

[44]  A. K. Calgarotto,et al.  Overexpression of α‐synuclein in an astrocyte cell line promotes autophagy inhibition and apoptosis , 2018, Journal of neuroscience research.

[45]  W. Chilian,et al.  Reactive Oxygen Species: The Good and the Bad , 2017 .

[46]  S. Hosseinkhani,et al.  Investigation of the effects of carbon-based nanomaterials on A53T alpha-synuclein aggregation using a whole-cell recombinant biosensor , 2017, International journal of nanomedicine.

[47]  Rafael Radi,et al.  Multifunctional Cytochrome c: Learning New Tricks from an Old Dog. , 2017, Chemical reviews.

[48]  Jochen H Weishaupt,et al.  Proteasome impairment by α-synuclein , 2017, PloS one.

[49]  Jia Liu,et al.  Pink1 interacts with α-synuclein and abrogates α-synuclein-induced neurotoxicity by activating autophagy , 2017, Cell Death and Disease.

[50]  A. Abramov,et al.  Alpha-synuclein and beta-amyloid - different targets, same players: calcium, free radicals and mitochondria in the mechanism of neurodegeneration. , 2017, Biochemical and biophysical research communications.

[51]  Ping Li,et al.  Caspase-9: structure, mechanisms and clinical application , 2017, Oncotarget.

[52]  J. Hardy,et al.  Dual Site Phosphorylation of Caspase-7 by PAK2 Blocks Apoptotic Activity by Two Distinct Mechanisms. , 2017, Structure.

[53]  J. Volkmann,et al.  Parkinson disease , 2017, Nature Reviews Disease Primers.

[54]  M. Ingelsson.  Alpha-Synuclein Oligomers—Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders , 2016, Front. Neurosci..

[55]  M. Beal,et al.  Mitochondrial dysfunction in Parkinson's disease , 2016, Journal of neurochemistry.

[56]  Michael J. Devine,et al.  Alpha-Synuclein Oligomers Interact with Metal Ions to Induce Oxidative Stress and Neuronal Death in Parkinson's Disease , 2016, Antioxidants & redox signaling.

[57]  E. Bézard,et al.  Alpha‐synuclein propagation: New insights from animal models , 2016, Movement disorders : official journal of the Movement Disorder Society.

[58]  S. Xiao,et al.  A novel firefly luciferase biosensor enhances the detection of apoptosis induced by ESAT-6 family proteins of Mycobacterium tuberculosis. , 2014, Biochemical and biophysical research communications.

[59]  J. Belizário,et al.  Cell Death-Associated Molecular-Pattern Molecules: Inflammatory Signaling and Control , 2014, Mediators of inflammation.

[60]  S. Tait,et al.  Killing the Killer: PARC/CUL9 Promotes Cell Survival by Destroying Cytochrome c , 2014, Science Signaling.

[61]  Y. Xiong,et al.  The E3 ligase PARC mediates the degradation of cytosolic cytochrome c to promote survival in neurons and cancer cells , 2014, Science Signaling.

[62]  S. Hosseinkhani,et al.  Effects of 940 MHz EMF on bioluminescence and oxidative response of stable luciferase producing HEK cells , 2014, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[63]  C. Proud,et al.  Eukaryotic elongation factor 2 kinase, an unusual enzyme with multiple roles. , 2014, Advances in biological regulation.

[64]  Andy Kilianski,et al.  Assessing Activity and Inhibition of Middle East Respiratory Syndrome Coronavirus Papain-Like and 3C-Like Proteases Using Luciferase-Based Biosensors , 2013, Journal of Virology.

[65]  Chu-Chiao Wu,et al.  Regulation of the intrinsic apoptosis pathway by reactive oxygen species. , 2013, Antioxidants & redox signaling.

[66]  T. Schäffer,et al.  Oxidative stress-induced posttranslational modifications of alpha-synuclein: Specific modification of alpha-synuclein by 4-hydroxy-2-nonenal increases dopaminergic toxicity , 2013, Molecular and Cellular Neuroscience.

[67]  A. Godzik,et al.  Evolution of the animal apoptosis network. , 2013, Cold Spring Harbor perspectives in biology.

[68]  M. Xilouri,et al.  Alpha-synuclein and Protein Degradation Systems: a Reciprocal Relationship , 2013, Molecular Neurobiology.

[69]  H. McBride,et al.  Calpain-mediated Processing of p53-associated Parkin-like Cytoplasmic Protein (PARC) Affects Chemosensitivity of Human Ovarian Cancer Cells by Promoting p53 Subcellular Trafficking* , 2011, The Journal of Biological Chemistry.

[70]  S. Chasovskikh,et al.  α-Synuclein Alters Toll-Like Receptor Expression , 2011, Front. Neurosci..

[71]  C. Ross,et al.  Curcumin protects against A53T alpha-synuclein-induced toxicity in a PC12 inducible cell model for Parkinsonism. , 2011, Pharmacological research.

[72]  Matthew D. Smith,et al.  Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. , 2011, Cancer research.

[73]  G. Salvesen,et al.  Regulation of the Apaf-1–caspase-9 apoptosome , 2010, Journal of Cell Science.

[74]  H. Soreq,et al.  Alanine-to-threonine substitutions and amyloid diseases: butyrylcholinesterase as a case study. , 2010, Chemico-biological interactions.

[75]  R. Youle,et al.  The role of mitochondria in apoptosis*. , 2009, Annual review of genetics.

[76]  M. Parihar,et al.  Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. , 2009, The international journal of biochemistry & cell biology.

[77]  D. Moore,et al.  Clearance and Phosphorylation of Alpha-Synuclein Are Inhibited in Methionine Sulfoxide Reductase A Null Yeast Cells , 2009, Journal of Molecular Neuroscience.

[78]  M. Beal,et al.  Mitochondrial dysfunction in the limelight of Parkinson's disease pathogenesis. , 2009, Biochimica et biophysica acta.

[79]  Kostas Vekrellis,et al.  Inducible over‐expression of wild type α‐synuclein in human neuronal cells leads to caspase‐dependent non‐apoptotic death , 2009, Journal of neurochemistry.

[80]  M. Sierks,et al.  Detecting Morphologically Distinct Oligomeric Forms of α-Synuclein* , 2009, Journal of Biological Chemistry.

[81]  W. Dauer,et al.  The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration , 2009, The Journal of Neuroscience.

[82]  Christopher Gerner,et al.  Executioner caspase-3 and caspase-7 are functionally distinct proteases , 2008, Proceedings of the National Academy of Sciences.

[83]  A. Gorman,et al.  Neuronal cell death in neurodegenerative diseases: recurring themes around protein handling , 2008, Journal of cellular and molecular medicine.

[84]  Frank Fan,et al.  Novel genetically encoded biosensors using firefly luciferase. , 2008, ACS chemical biology.

[85]  N. Avadhani,et al.  Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain* , 2008, Journal of Biological Chemistry.

[86]  M. Toledano,et al.  ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis , 2007, Nature Reviews Molecular Cell Biology.

[87]  M. Sierks,et al.  Isolation of a human single chain antibody fragment against oligomeric α-synuclein that inhibits aggregation and prevents α-synuclein induced toxicity , 2007 .

[88]  Yigong Shi,et al.  Apoptosome: a platform for the activation of initiator caspases , 2007, Cell Death and Differentiation.

[89]  C. Duan,et al.  [Overexpression of alpha-synuclein in SH-SY5Y cells partially protected against oxidative stress induced by rotenone]. , 2006, Sheng li xue bao : [Acta physiologica Sinica].

[90]  S. Fulda,et al.  Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy , 2006, Oncogene.

[91]  C. Ross,et al.  Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. , 2005, Human molecular genetics.

[92]  A. Kanthasamy,et al.  Wild-type α-synuclein interacts with pro-apoptotic proteins PKCδ and BAD to protect dopaminergic neuronal cells against MPP+-induced apoptotic cell death , 2005 .

[93]  J. Keller,et al.  α-Synuclein Alters Proteasome Function, Protein Synthesis, and Stationary Phase Viability* , 2005, Journal of Biological Chemistry.

[94]  Smita Patel,et al.  Intravesicular Localization and Exocytosis of α-Synuclein and its Aggregates , 2005, The Journal of Neuroscience.

[95]  Y. Suh,et al.  α‐Synuclein induces apoptosis by altered expression in human peripheral lymphocytes in Parkinson’s disease , 2004 .

[96]  J. Qin,et al.  Parc A Cytoplasmic Anchor for p53 , 2003, Cell.

[97]  E. Masliah,et al.  α-Synuclein Protects against Oxidative Stress via Inactivation of the c-Jun N-terminal Kinase Stress-signaling Pathway in Neuronal Cells* , 2002, The Journal of Biological Chemistry.

[98]  E. Junn,et al.  Human α-Synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine , 2002, Neuroscience Letters.

[99]  M. Clemens,et al.  Inhibition of Protein Synthesis in Apoptosis: Differential Requirements by the Tumor Necrosis Factor Family and a DNA-damaging Agent for Caspases and the Double-stranded RNA-dependent Protein Kinase , 2002 .

[100]  N. Tatton.  Increased Caspase 3 and Bax Immunoreactivity Accompany Nuclear GAPDH Translocation and Neuronal Apoptosis in Parkinson's Disease , 2000, Experimental Neurology.

[101]  A. Davies,et al.  Induction of neuronal death by α‐synuclein , 2000, The European journal of neuroscience.

[102]  R. Lloyd,et al.  Identification of Caspase 3-mediated Cleavage and Functional Alteration of Eukaryotic Initiation Factor 2α in Apoptosis* , 2000, The Journal of Biological Chemistry.

[103]  H. Ichinose,et al.  Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain , 2000, Journal of Neural Transmission.

[104]  Y. Lin,et al.  Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. , 1999, Genes & development.

[105]  W. Tatton,et al.  Apoptosis in neurodegenerative diseases: the role of mitochondria. , 1999, Biochimica et biophysica acta.

[106]  A. Porter,et al.  Emerging roles of caspase-3 in apoptosis , 1999, Cell Death and Differentiation.

[107]  R. Lloyd,et al.  Eukaryotic Translation Initiation Factor 4G Is Targeted for Proteolytic Cleavage by Caspase 3 during Inhibition of Translation in Apoptotic Cells , 1998, Molecular and Cellular Biology.

[108]  C. G. Jones,et al.  Mechanism of dye response and interference in the Bradford protein assay. , 1985, Analytical biochemistry.

[109]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.